Search Results - "Kase, Adam"

Efficacy of gemcitabine in combination with nanoparticle albumin‐bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.

Authors: Kase, Adam M. Azzouqa, Abdel‐Ghani Kochuveettil, Swapna et al.

Source: Cancer Medicine. Apr2023, Vol. 12 Issue 8, p9434-9438. 5p.

Clear Cell Renal Cell Carcinoma: From Biology to Treatment.

Authors: Kase, Adam M. George, Daniel J. Ramalingam, Sundhar

Source: Cancers. Feb2023, Vol. 15 Issue 3, p665. 15p.

A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer.

Authors: Parent, Ephraim E. Kase, Adam M.

Source: Cancers. Sep2022, Vol. 14 Issue 17, p4276. 19p.

Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T.

Authors: Kase, Adam M. Kharfan‐Dabaja, Mohamed A. Donaldson, Andrew et al.

Source: Clinical Case Reports. Apr2022, Vol. 10 Issue 4, p1-5. 5p.

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer.

Authors: Kase, Adam M. Tan, Winston Copland III, John A. et al.

Source: Cancers. Mar2022, Vol. 14 Issue 6, p1361. 11p.

Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer.

Authors: Kase, Adam M III, John A Copland Tan, Winston

Source: OncoTargets & Therapy. Oct2020, Vol. 13, p10499-10513. 15p.

Complete response in Patients With Lung-Only Metastatic Prostate Cancer: Outcome Analysis.

Authors: Kase, Adam M. Copland III, John A. Qihui Zhai et al.

Source: Clinical Genitourinary Cancer. Dec2022, Vol. 20 Issue 6, pe485-e489. 5p.

Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.

Authors: Muniz, Miguel Tsai, L. Jill Orme, Jacob J. et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p3048. 14p.

Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy.

Authors: Seby, Robert McCormick, Benjamin J Wolf, Emily et al.

Source: Journal of Blood Medicine. Jul2025, p331-335. 5p.

Closing the Gap in Direct Admissions: A Quality Improvement Project.

Authors: McKenna, Amanda L. Carter, Laurel E. Kase, Adam M. et al.

Source: Quality Management in Health Care. Jan-Mar2024, Vol. 33 Issue 1, p52-58. 7p.

Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [¹⁷⁷Lu]Lu-PSMA-617.

Authors: Muniz, Miguel Sartor, Oliver Orme, Jacob J. et al.

Source: Journal of Nuclear Medicine. Dc2024, Vol. 65 Issue 12, p1932-1938. 7p.

The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.

Authors: Shukla, Sanjeev Riveros, Carlos Al-Toubat, Mohammed et al.

Source: Cancers. Aug2023, Vol. 15 Issue 15, p3851. 12p.

LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors: Zarka, Jabra Juthani, Ronit Sartor, Oliver et al.

Source: Clinical Genitourinary Cancer. Jun2026, Vol. 24 Issue 4, pN.PAG-N.PAG. 1p.

Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective Analysis.

Authors: Jain, Prateek Naqvi, Syed Arsalan Ahmed Tripathi, Nikita et al.

Source: Clinical Genitourinary Cancer. Dec2025, Vol. 23 Issue 6, pN.PAG-N.PAG. 1p.

Lower SYNJ2BP Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis.

Authors: Saulsbury MD Heyliger SO Taioli E et al.

Source: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2025 Nov-Dec; Vol. 22 (6), pp. 863-881.

Publication Type: Journal Article

Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium: Internet ISSN: 1790-6245 (Electronic) Linking ISSN: 11096535 NLM ISO Abbreviation: Cancer Genomics Proteomics Subsets: MEDLINE

Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma.

Authors: Heyliger S Turley TN Roach T et al.

Source: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2025 Sep-Oct; Vol. 22 (5), pp. 698-715.

Publication Type: Journal Article

Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium: Internet ISSN: 1790-6245 (Electronic) Linking ISSN: 11096535 NLM ISO Abbreviation: Cancer Genomics Proteomics Subsets: MEDLINE

Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [¹⁷⁷Lu]Lu-PSMA-617.

Authors: Muniz M Sartor O Orme JJ et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Dec 03; Vol. 65 (12), pp. 1932-1938. Date of Electronic Publication: 2024 Dec 03.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

ALK-Rearranged renal neoplasms: update on an institutional cohort.

Authors: Arizpe D Gallan AJ Kase AM et al.

Source: Virchows Archiv : an international journal of pathology [Virchows Arch] 2025 Dec; Vol. 487 (6), pp. 1423-1431. Date of Electronic Publication: 2025 Oct 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE

Outcomes for [¹⁷⁷Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.

Authors: Muniz M Sartor O Orme JJ et al.

Source: European urology oncology [Eur Urol Oncol] 2025 Aug; Vol. 8 (4), pp. 1087-1093. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy.

Authors: Muniz M Childs DS Andrews J et al.

Source: Annals of translational medicine [Ann Transl Med] 2025 Jun 27; Vol. 13 (3), pp. 29. Date of Electronic Publication: 2025 Jun 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101617978 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2305-5839 (Print) Linking ISSN: 23055839 NLM ISO Abbreviation: Ann Transl Med Subsets: PubMed not MEDLINE